Skip to main content
Caplight Logo









Stimdia Medical

Stimdia Medical

Private
Mendota Heights, MinnesotaHealthcare & Life Scienceshttps://stimdia.com/

Last Round

Series B

Jul 14, 2022

Total Funding Raised

$18M

Company Overview

Stimdia Medical is a medical device company that develops a non-invasive lung pacing device aimed at expediting the weaning process for patients on mechanical ventilation, thereby minimizing health risks.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurostimulationdiaphragm pacingventilator-induced diaphragm dysfunctionVIDDmedical devicephrenic nerve stimulationcritical care technologyneuromodulationtranscutaneous electrical nerve stimulationTENSmechanical ventilationrespiratory therapyICU equipmentmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stimdia Medical Comparables

Compare Stimdia Medical with similar companies based on industry and business-model similarity.

Stimdia Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Liberate Medical
93%
Lungpacer Medical
89%
Hamilton Medical AG
85%

Stimdia Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 14, 2022
SeedDec 18, 2019
Series AMar 6, 2017

Key People

Founding team and executive leadership

Allen Meacham

President and Chief Executive Officer

Executive Team

Scott Youngstrom

Chief Financial Officer

Executive Team

Stimdia Medical Investors

Notable investors and investment history

Stimdia Medical investors
InvestorRounds
Piedmont Capital PartnersSeed
University of MinnesotaSeed
Magarac Venture PartnersSeries B
Solas BioVenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 14, 2022

    $16M round led by Solas BioVentures.

Stimdia Medical Filings

Explore SEC and related filing metadata, where available.

Stimdia Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Stimdia Medical's valuation, stock price, and market status.

Is Stimdia Medical a public or private company?

Stimdia Medical is a private company.

What is the current stock price of Stimdia Medical?

Stimdia Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Stimdia Medical worth (valuation)?

Valuation information for Stimdia Medical is not publicly available.

Can I buy Stimdia Medical stock?

Stimdia Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Stimdia Medical's last funding round?

Stimdia Medical's most recent funding round was Series B on June 29, 2022.

Who are the main investors in Stimdia Medical?

Key investors in Stimdia Medical include Solas BioVentures.

Will Stimdia Medical IPO soon?

No public IPO plans have been announced for Stimdia Medical.

How can I track Stimdia Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stimdia Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMendota Heights, Minnesota
Employee Range14
Year Founded2015
Last FundingJul 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?